top of page
A black and white gradient


Proven safe and effective, Botox, Xeomin, and Dysport are FDA-approved for the treatment of moderate to severe frown lines and wrinkles. Also known as “neuro-modulators”, these injectables temporarily alter nerve impulses of targeted muscles. These injectables most commonly treat the horizontal lines across the forehead, as well as the “elevens,” the two perpendicular lines that form between the brows when we frown. Botox, Xeomin, & Dysport are also excellent treatments for crow’s feet, the fine lines that appear around the corners of the eyes. At Fourth N Main Modern Aesthetics, a customized treatment plan will be developed for you to provide you with a natural-looking, more youthful appearance.

a person injecting a person's face
A blank screen with lines


We’re pleased to introduce DAXXIFY™–the only long-lasting, peptide-powered frown line treatment. Fourth N Main Modern Aesthetics in Asbury Park, NJ is one of the first exclusive providers to offer this innovative treatment. Looking for a longer lasting neuromodulator? Consider trying DAXXIFY™.  DAXXIFY™ is FDA approved to help smooth moderate to severe lines between the brows. It is the only long-lasting frown line treatment powered by a peptide with results that last on average 6 months and up to 9 months for some.  Conventional injectables last 3 – 4 months and require up to 4 treatments a year to maintain results. Nearly 90% of patients say they wish results lasted longer. With DAXXIFY™ you can keep your frown lines smoother for a full year with as few as 2 treatments.

a chair in a room

learn more


    Kybella is a refined version of a substance called deoxycholic acid, which is naturally produced by your body. Deoxycholic acid’s primary role is assisting with fat absorption.
    It destroys fat cells wherever it is injected, causing them to be absorbed by the body. When injected into the fat beneath your chin, Kybella causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. This makes Kybella an innovative and ideal new way for patients to gain some of the benefits of liposuction for a double chin without surgery. Prior to approval in May of 2015 by the Food and Drug Administration, Kybella was the subject of medical trials that included more than 1,000 individuals. The results showed that eight out of ten people who received Kybella had a loss of chin fat.
    Most people who have a double chin feel self-conscious about the fullness. To make matters worse, extra fat in this region may not go away with diet and exercise. A lot of individuals who struggle with double chins avoid liposuction for their problem because they worry about the costs, downtime, and invasiveness. Fortunately, Kybella offers a cutting-edge new way to solve double chins without these obstacles.
    Many patients experience visible contouring of their chin profile in two to four treatment sessions spaced at least one month apart on average. Once the desired aesthetic response is achieved with Kybella, re-treatment is not expected.
Fourth-N-Main Logo
bottom of page